NASDAQ
IXHL
Last Price
US $3.16
KEY FIGURES
MKT CAP
$37.8M
EPS
TTM
$-4.04
EPS Growth (1Y)
1092.98%
PEG
TTM
N/M
P/E
TTM
N/M
P/S
TTM
-
YIELD
-
GROWTH (5Y CAGR)
Revenue
Valuation
Financial
Performance
Cash flow to debt coverage
Incannex Healthcare Limited cash flow to debt ratio of -4.85K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
Incannex Healthcare Limited's free cash flow has increased -22.34% from $-16.12M last year to $-12.52M, signaling increasing performance
Debt-to-equity ratio
Incannex Healthcare Limited's debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
Incannex Healthcare Limited's debt has decreased relative to shareholder equity from 0.03 last year to 0.00 today, signaling strengthened financials
Net debt to EBITDA
Incannex Healthcare Limited has a net cash position, so leverage is healthy.
Interest coverage
Incannex Healthcare Limited's interest coverage ratio is -131.94, which means that the company struggles to meet interest obligations, signaling financial risk.
Profit margin growth
Incannex Healthcare Limited's profit margin has increased (-51.26%) in the last year from -153.82K% to -74.97K%, signaling increasing performance
Current ratio
Incannex Healthcare Limited's short-term assets of $19.96M exceed its short-term liabilities of $6.98M
Return on assets
Incannex Healthcare Limited's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Incannex Healthcare Limited's return on equity of -92.47%, is lower than 15.00%, indicating bad performance
Earnings quality
Incannex Healthcare Limited's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
Incannex Healthcare Limited has insufficient public price history to evaluate earnings stability.
Positive free cash flow
Incannex Healthcare Limited has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
Incannex Healthcare Limited has negative free cash flow, indicating cash burn
Earnings growth
Incannex Healthcare Limited's yearly earnings has decreased 154.00% since last year from $-18.46M to $-46.88M, signaling decreasing performance
Revenue growth
Incannex Healthcare Limited's yearly revenue has increased 378.70% since last year from $17.97K to $86.00K, signaling increasing performance
Return on invested capital
ROIC -44.41% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
Incannex Healthcare Limited's 3-year revenue CAGR of -52.15% is negative, indicating declining revenue over the past 3 years
Revenue consistency
Incannex Healthcare Limited had revenue growth in 3 out of 5 years, indicating consistent revenue performance
Return on equity consistency
Incannex Healthcare Limited has insufficient public price history to evaluate ROE consistency.
Cash Flow Valuation (DCF)
Incannex Healthcare Limited has insufficient data to evaluate this check.
Earnings yield (TTM)
Incannex Healthcare Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
Incannex Healthcare Limited is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
Incannex Healthcare Limited has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
Incannex Healthcare Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
Incannex Healthcare Limited has a price-to-book ratio of 0.53x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
Incannex Healthcare Limited has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
-92.47%
Return on equity
ROIC: -44.41%
Valuation History
-
Price to Earnings
EV/EBITDA: 0.69X
Cash flow
Profit margin
-32.19%
EBITDA
-29.64%
Cash flow
-20.84%
Cash Flow (DCF)
Fair Value
Market $3.16
—
Default assumptions
EBITDA Multiple
Fair Value
Market $3.16
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.